United Health To Congress: Let Cancer Patients Eat Gauze (Op-Ed in The Hill)
Jonathan Wilcox’s op-ed in The Hill today highlights the growing challenge of insurance company tactics that contribute to increased costs to the health care system and restricted patient access to...
View ArticleBIO 2015 Kicks Off: Patient-Focused Drug Development Key Theme of Day One
The BIO International Convention kicked off in Philadelphia today with a strong emphasis on patient-focused drug development as a seismic shift in the way drugs are developed and delivered. The...
View ArticleClik here to view.
Wall Street Journal: Patients Deserve Better
In case you missed it, The Wall Street Journal published my Letter to the Editor this morning. I make the point that the problem isn’t innovative new treatments from America’s biopharma industry but...
View ArticleOrphan Drug Tax Credit is Crucial to Rare Disease R&D
The term “rare disease” may be misleading: to be “rare” a disease must effect fewer than 200,000 people in the U.S., but there are over 7,000 rare diseases that have been identified. Taken together,...
View ArticleClik here to view.
BIO Principles Put Patients First
Patient advocacy organizations play an indispensable role in the biopharmaceutical development process: They help scientists and researchers better understand what it’s like to live with the diseases...
View ArticleClik here to view.
Welcome to the 2017 BIO Patient and Health Advocacy Summit!
Patients are at the forefront of everything we do. Each year BIO brings the patient stakeholder community together at the BIO Patient and Health Advocacy Summit to network, to learn, to engage, to...
View ArticleClik here to view.
Understanding the Patient Voice: Unique Perspectives on Healthcare
To end Day 2 of Education Tracks at the 2018 BIO International Convention, Julie Gerberding, Executive Vice President & Chief Patient Officer, Merck & Com Inc. led a discussion with three...
View ArticleClik here to view.
Better Understanding the Patient Voice at BIO 2018
Day Three of Educational Tracks at #BIO2018 included a panel on ‘Best Practices for Working with Patient Advocacy Organizations.’ Led by Karlin Schroeder, MA, Director of Community Engagement with the...
View ArticleClik here to view.
A Patient-Centric Approach to Investing & Partnering
Thursday’s Plenary Luncheon Fireside Chat at the 2018 BIO Investor Forum (BIF) featured two industry leaders: Rowan Chapman, PhD., head of Johnson & Johnson Innovation, California, and moderator...
View ArticleClik here to view.
BIO Patient & Health Advocacy Summit Concludes Today
Each year BIO brings the patient stakeholder community together for the BIO Patient and Health Advocacy Summit to network; to learn; to engage; to partner; and to discover. Held this year—its...
View Article